Q32 Bio (QTTB) Total Liabilities (2017 - 2026)

Q32 Bio's Total Liabilities history runs 10 years deep, the most recent figure standing at $17.4 million for Q1 2026.

• In Q1 2026, Total Liabilities fell 79.1% year-over-year to $17.4 million; the TTM figure through Mar 2026 stood at $17.4 million (down 79.1% YoY), while the FY2025 annual figure was $19.8 million, down 77.2% from the prior year.
• Total Liabilities was $17.4 million for Q1 2026 at Q32 Bio, down from $19.8 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $118.5 million in Q4 2023 to a low of $17.4 million in Q1 2026.
• Historically, Total Liabilities has averaged $64.8 million across 5 years, with a median of $53.6 million in 2022.
• The sharpest annual moves came in 2023 and 2026: Total Liabilities soared 134.76% in 2023, then tumbled 79.1% in 2026.
• A 5-year view of Total Liabilities shows it stood at $50.5 million in 2022, then jumped by 134.76% to $118.5 million in 2023, then slipped by 26.89% to $86.7 million in 2024, then plunged by 77.2% to $19.8 million in 2025, then retreated by 12.14% to $17.4 million in 2026.
• The last three Total Liabilities figures came in at $17.4 million (Q1 2026), $19.8 million (Q4 2025), and $76.2 million (Q3 2025), per Business Quant data.